Serica Jianxin Venture Capital

Serica Jianxin is a venture capital firm specializing in cross-border healthcare and life sciences investments, primarily bridging Western innovation with the Chinese market. A partnership between Serica Capital and Jianxin (CCB Trust), the firm focuses on clinical-stage biotechnology, medical devices, and digital health sectors. They provide strategic value to portfolio companies by assisting with regulatory navigation, clinical trial management, and commercialization strategies within China. The firm's investment approach leverages the financial backing of China Construction Bank's ecosystem to support high-growth healthcare entities. Their portfolio includes innovative companies across oncology, cardiovascular health, and diagnostic technologies.